Artivion | CRY - Ebitda


Artivion reported $22.72M in EBITDA for its fiscal quarter ending in December of 2025.





Ebitda Change Date
Abbott USD 2.43B 844M Mar/2026
Accuray USD -685K 900K Sep/2024
AngioDynamics USD 5.94M 3.78M Sep/2025
Artivion USD 22.72M 1.84M Dec/2025
AtriCure USD 27.28M 10.21M Jun/2026
Baxter International USD 309M 756M Mar/2026
Becton, Dickinson and Co. USD 1.71B 1B Jun/2026
Boston Scientific USD 1.63B 27M Jun/2026
Edwards Lifesciences USD 555.6M 485.5M Mar/2026
Integra LifeSciences USD 78.41M 2.23M Jun/2026
J&J USD 8.27B 1.08B Mar/2026
Mesa Laboratories USD 9.58M 1.47M Sep/2024
Orthofix International USD 27.88M 2.77M Dec/2025
Pfizer USD 6.01B 18M Jun/2026
ResMed USD 559.78M 9.06M Jun/2026
Stryker USD 1.93B 357M Jun/2026
Tandem Diabetes Care USD 6.42M 3.69M Jun/2026
Teleflex USD 75.63M 171.44M Mar/2026
Terumo JPY 116.67B 58.79B Jun/2026
Trinity Biotech USD -9.6M 7.64M Dec/2024